Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

295.19
+3.741.28%
Post-market: 295.190.00000.00%19:38 EDT
Volume:887.56K
Turnover:262.16M
Market Cap:14.09B
PE:-60.47
High:298.18
Open:291.78
Low:289.07
Close:291.45
52wk High:299.32
52wk Low:144.26
Shares:47.74M
Float Shares:47.20M
Volume Ratio:1.02
T/O Rate:1.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8814
EPS(LYR):-2.9122
ROE:-7.52%
ROA:4.11%
PB:4.96
PE(LYR):-101.36

Loading ...

Movement Alert|Charles River Laboratories Rises 8.06% in Pre-Market Trading, Q2 Earnings Beat Across the Board with Full-Year Guidance Raised

Market Focus
·
Aug 05

Charles River Laboratories Shares up 8.1% Premarket After Co Lifts FY Profit Forecast

THOMSON REUTERS
·
Aug 05

Charles River Lifts Profit Forecast on Improving Biotech Demand

Reuters
·
Aug 05

Charles River Laboratories Tops Q2 Revenue and Profit Estimates

Reuters
·
Aug 05

GUIDANCE: (CRL) Charles River Laboratories Expects 2026 Adjusted EPS Range $11.15 - $11.45, vs. FactSet Est of $11.11

MT Newswires Live
·
Aug 05

Earnings Flash (CRL) Charles River Laboratories Posts Fiscal Q2 Revenue $1.00B, vs. FactSet Est of $977.2M

MT Newswires Live
·
Aug 05

Charles River Q2 FY26 GAAP EPS Swings to Loss of $(0.03); Revenue Falls 2.7% to $1 Billion

Reuters
·
Aug 05

Charles River Q2 Adjusted EPS USD 3.02 Vs. IBES Estimate USD 2.74

Reuters
·
Aug 05

Charles River Outlook FY Revenue Growth -3.5 to -2.5%

THOMSON REUTERS
·
Aug 05

Charles River Outlook FY Adjusted EPS USD 11.15-11.45

THOMSON REUTERS
·
Aug 05

Charles River Q2 EPS USD -0.03

THOMSON REUTERS
·
Aug 05

Charles River Laboratories International Inc. Stock Rises Tuesday, Still Underperforms Market

Dow Jones
·
Aug 05

Press Release: Pharming Reports Second Quarter and First Half 2026 Financial Results and Revises Year-end Guidance; Strong Joenja Momentum and Near-term Clinical Readouts to Support Broader Therapeutic Use

Dow Jones
·
Jul 30

Charles River Laboratories International Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 30

Earning Preview: Charles River Laboratories Q2 revenue expected to decrease by 1.05%, and institutional views are mixed-to-positive

Earnings Agent
·
Jul 29

Movement Alert|Charles River Laboratories Rises 7.74% in Regular Trading, CRO Sector Rallies as Multiple Banks Raise Price Targets

Market Focus
·
Jul 28

Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration

GlobeNewswire
·
Jul 28

Charles River Laboratories International Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 28

Charles River Laboratories International Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 25

Charles River Laboratories International Inc. Stock Advances 4.8%, Outperforms Peers

Dow Jones
·
Jul 24